LITH Competitors

LITH Stock  USD 0.0001  0.00  0.00%   
Relative analysis here focuses on where US Lithium is stronger or weaker than peers.

Pair Correlation for US Lithium and Micro Imaging Snapshot

Moving against LITH Stock

  0.72MRK Merck CompanyPairCorr
  0.64NVS Novartis AG ADRPairCorr
  0.59BKRKF PT Bank RakyatPairCorr
  0.54JNJ Johnson JohnsonPairCorr
  0.49AZN AstraZeneca PLCPairCorr
Specify up to 10 symbols:
The degree to which US Lithium's exhibits mean reversion depends on how efficiently the market prices new information. In highly covered equities, the mean reversion window tends to be shorter.
Hype
Prediction
LowEstimatedHigh
0.000.00016.35
Details
Intrinsic
Valuation
LowRealHigh
0.000.0000966.35
Details
Naive
Forecast
LowNextHigh
0.0000020.00016.35
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.00010.00010.0001
Details
Before investing in US Lithium, assess how US Lithium's compares to its competitive peer group. A company that appears undervalued in absolute terms may be fairly priced when measured against sector-relative benchmarks.

US Lithium Competition Correlation Matrix

Correlation analysis between US Lithium Corp and its competitors helps investors understand whether diversification is real or only superficial inside the same peer group. This matrix is most informative when investors want to know whether adding another peer would improve diversification, increase crowding, or leave total risk largely unchanged.

High positive correlations

PJETAMHD
OMMHAMHD
MMTCAMHD
OMMHPJET
MMTCPJET
MMTCOMMH
  

High negative correlations

CFRXQMILC
UTRSMILC
CFRXQDMKPQ
UTRSDMKPQ
MILCDMKPQ
CFRXQEFTR

Risk-Adjusted Indicators

There is a big difference between LITH Stock performing well and US Lithium Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze US Lithium's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Peer Comparison: Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in US Lithium Corp financial statement analysis. It represents the amount of money remaining after all of US Lithium Corp operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.
Compare US Lithium Corp and related stocks such as DMK Pharmaceuticals, HLK Biotech Holding, and Millennium Investment Net Income Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Shareholders Equity Per ShareDebt To Equity
Capex Per ShareGraham Net Net
Average ReceivablesRevenue Per Share
Interest Debt Per ShareDebt To Assets
Enterprise Value Over E B I T D AShort Term Coverage Ratios
Price Earnings RatioOperating Cycle
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Cash Conversion CycleOperating Cash Flow Sales Ratio
Days Of Inventory OutstandingDays Of Sales Outstanding
Free Cash Flow Operating Cash Flow RatioCash Flow Coverage Ratios
Price To Book RatioFixed Asset Turnover
Capital Expenditure Coverage RatioPrice Cash Flow Ratio
Enterprise Value MultipleDebt Ratio
Cash Flow To Debt RatioPrice Sales Ratio
Return On AssetsAsset Turnover
Net Profit MarginGross Profit Margin
Price Fair ValueReturn On Equity
20102011201220132014201520162017201820192020202120222023202420252026
EFTR-29.7 M-29.7 M-29.7 M-29.7 M-29.7 M-29.7 M-29.7 M-29.7 M-29.7 M-29.7 M14.2 M15.8 M-12.9 M-35.8 M-35.8 M-32.2 M-30.6 M
OMMH-47.6 K-1.8 M-1.8 M-1.8 M-1.8 M-1.8 M-1.8 M-1.8 M-1.8 M-1.8 M-1.8 M-1.8 M-1.8 M-1.8 M-1.8 M-1.6 M-1.7 M

US Lithium Competitive Analysis

Placing US Lithium next to HLK Biotech, Millennium Investment, and Priority Aviation puts raw numbers into competitive context. A 940 valuation is the starting point. US Lithium posts a -598.11% return on equity, reflecting current earnings headwinds. On pure scale, HLK Biotech is the bigger entity with market caps of 462,456 versus 940. US Lithium carries a higher earnings multiple of 11.85x compared to 2.66x for Millennium Investment. On pure scale, Priority Aviation is the bigger entity with market caps of 465,455 versus 940.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
LITH DMKPQ AMHD MILC PJET EFTR UTRS OMMH MMTC
 0.00 
0.0001
LITH
 0.00 
0.0001
DMK
 0.00 
0.0002
HLK
 0.00 
0.0002
Millennium
 0.00 
0.0001
Priority
 66.67 
0.0002
Effector
 0.00 
0.0001
Minerva
 0.00 
0.0001
Omnimmune
 0.00 
0.0001
Micro
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Analysis
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Current Ratio
Net Asset
Profit Margin
EBITDA
Current Valuation
Price To Book
Operating Margin
Current Asset
Retained Earnings
Beta
Number Of Employees
Shares Outstanding
Cash Flow From Operations
Total Debt
Return On Equity
Z Score
Return On Asset
Book Value Per Share
Number Of Shares Shorted
Current Liabilities
Total Asset
Debt To Equity
Short Ratio
Target Price
Shares Owned By Institutions
Market Capitalization
Price To Earning
Price To Sales
Net Income
Earnings Per Share
Shares Owned By Insiders
Revenue
Working Capital
Cash And Equivalents
Cash Per Share
Gross Profit
Day Typical Price
Period Momentum Indicator
Rate Of Daily Change
Day Median Price
Price Action Indicator
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Standard Deviation
Kurtosis
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Information Ratio

Peer Performance Charts

How to Analyze US Lithium Against Peers

US Lithium's peer analysis compares US Lithium with related companies to put valuation, quality, and risk metrics in context. This helps determine whether recent performance is company-specific or broadly sector-driven. A practical workflow includes:
  • Set a relevant peer group: Include direct competitors and close alternatives with comparable business exposure.
  • Benchmark core financials: Compare profitability, growth, capital structure, and cash flow quality.
  • Check valuation dispersion: Review whether US Lithium trades at a premium or discount versus peers and why.
  • Evaluate risk profile: Compare volatility, drawdowns, and correlation to avoid false diversification assumptions.
  • Document the thesis: Record where US Lithium leads or lags and what catalysts could close or widen the gap.
Use this as an educational baseline, then validate conclusions with current filings, market conditions, and portfolio objectives.